Imperva (IMPV) Tops Q3 EPS by 19c

Imperva (NYSE: IMPV) reported Q3 EPS of ($0.10), $0.19 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $42.7 million versus the consensus estimate of $40 million.

For earnings history and earnings-related data on Imperva (IMPV) click here.

You May Also Be Interested In

• Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
• UnitedHealth Group (UNH) Tops Q1 EPS by 29c, Tops on Revenue; Offers FY24 EPS Guidance
• UBS expects S&P 500 earnings growth at 7% to 9%